Filing Details

Accession Number:
0001181431-11-023812
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-13 16:09:01
Reporting Period:
2011-04-11
Filing Date:
2011-04-13
Accepted Time:
2011-04-13 16:09:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1234564 W Brian Metcalf Experimental Station
Route 141 &Amp; Henry Clay Road
Wilmington DE 19880
Chief Drug Discovery Scientist No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-04-11 100,000 $5.46 166,504 No 4 M Direct
Common Stock Disposition 2011-04-11 50,000 $17.40 116,504 No 4 S Direct
Common Stock Disposition 2011-04-11 50,000 $17.42 66,504 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non Qualified Stock Option (right to buy) Disposition 2011-04-11 82,688 $0.00 82,688 $5.46
Common Stock Incentive Stock Option (right to buy) Disposition 2011-04-11 17,312 $0.00 17,312 $5.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-01-12 No 4 M Direct
0 2016-01-12 No 4 M Direct
Footnotes
  1. Beginning January 13, 2006, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.